A multicentric, prospective, randomized, open label Phase IV clinical study to evaluate the safety and efficacy of Saroglitazar (ZYH1) as compared to fenofibrate in patients with dyslipidemia.

Trial Profile

A multicentric, prospective, randomized, open label Phase IV clinical study to evaluate the safety and efficacy of Saroglitazar (ZYH1) as compared to fenofibrate in patients with dyslipidemia.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Oct 2017

At a glance

  • Drugs Saroglitazar (Primary) ; Fenofibrate
  • Indications Dyslipidaemias
  • Focus Therapeutic Use
  • Acronyms PRESS X
  • Sponsors Cadila Healthcare
  • Most Recent Events

    • 20 Aug 2013 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India.
    • 03 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top